Not recruiting
Hepatic cirrhosis
Not recruitingStudy on the Effectiveness and Safety of Hepatitis B Surface Antigen and Imiquimod in Cirrhotic Patients Unresponsive to Conventional Vaccination
Registered drugNo placebo
Study on the Effectiveness and Safety of Hepatitis B Surface Antigen and Imiquimod in Cirrhotic Patients Unresponsive to Conventional Vaccination
Registered drugNo placebo
- Disease:Hepatic cirrhosis
- Substances:ImiquimodHepatitis B Surface Antigen
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Imiquimod
